250 related articles for article (PubMed ID: 30787927)
1. The
Jen FE; Semchenko EA; Day CJ; Seib KL; Jennings MP
Front Immunol; 2019; 10():137. PubMed ID: 30787927
[TBL] [Abstract][Full Text] [Related]
2. The
Semchenko EA; Day CJ; Seib KL
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32414194
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Recombinant
Almonacid-Mendoza HL; Humbert MV; Dijokaite A; Cleary DW; Soo Y; Hung MC; Orr CM; Machelett MM; Tews I; Christodoulides M
mSphere; 2018 Oct; 3(5):. PubMed ID: 30305317
[No Abstract] [Full Text] [Related]
4. MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.
Semchenko EA; Day CJ; Seib KL
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895130
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
[TBL] [Abstract][Full Text] [Related]
6. Refinement of immunizing antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae.
Shewell LK; Jen FE; Jennings MP
PLoS One; 2017; 12(8):e0182555. PubMed ID: 28771632
[TBL] [Abstract][Full Text] [Related]
7. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
[TBL] [Abstract][Full Text] [Related]
8. Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies.
Wang S; Xue J; Lu P; Ni C; Cheng H; Han R; van der Veen S
J Infect; 2018 Sep; 77(3):191-204. PubMed ID: 29902495
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
10. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
[TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
Baarda BI; Zielke RA; Holm AK; Sikora AE
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
[TBL] [Abstract][Full Text] [Related]
13. The outer membrane localization of the Neisseria gonorrhoeae MsrA/B is involved in survival against reactive oxygen species.
Skaar EP; Tobiason DM; Quick J; Judd RC; Weissbach H; Etienne F; Brot N; Seifert HS
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10108-13. PubMed ID: 12096194
[TBL] [Abstract][Full Text] [Related]
14. Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved
Martinez FG; Zielke RA; Fougeroux CE; Li L; Sander AF; Sikora AE
Infect Immun; 2023 Dec; 91(12):e0024523. PubMed ID: 37916806
[TBL] [Abstract][Full Text] [Related]
15. Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
Jiao H; Yang H; Zhao D; Chen J; Zhang Q; Liang J; Yin Y; Kong G; Li G
Vaccine; 2018 Jul; 36(30):4532-4539. PubMed ID: 29914847
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles.
Zhu W; Thomas CE; Chen CJ; Van Dam CN; Johnston RE; Davis NL; Sparling PF
Infect Immun; 2005 Nov; 73(11):7558-68. PubMed ID: 16239559
[TBL] [Abstract][Full Text] [Related]
17. Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens.
Wizemann TM; Moskovitz J; Pearce BJ; Cundell D; Arvidson CG; So M; Weissbach H; Brot N; Masure HR
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7985-90. PubMed ID: 8755589
[TBL] [Abstract][Full Text] [Related]
18. The thioredoxin domain of Neisseria gonorrhoeae PilB can use electrons from DsbD to reduce downstream methionine sulfoxide reductases.
Brot N; Collet JF; Johnson LC; Jönsson TJ; Weissbach H; Lowther WT
J Biol Chem; 2006 Oct; 281(43):32668-75. PubMed ID: 16926157
[TBL] [Abstract][Full Text] [Related]
19. Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.
Gulati S; Agarwal S; Vasudhev S; Rice PA; Ram S
J Immunol; 2012 Apr; 188(7):3416-25. PubMed ID: 22368277
[TBL] [Abstract][Full Text] [Related]
20. Salmonella Typhimurium methionine sulfoxide reductase A (MsrA) prefers TrxA in repairing methionine sulfoxide.
Dixit SK; Hota DP; Rajan P; Mishra PK; Goswami TK; Mahawar M
Prep Biochem Biotechnol; 2017 Feb; 47(2):137-142. PubMed ID: 27191346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
